方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 肌萎缩侧索硬化功能评定量表修订版 (ALSFRS-R)× | 多发性硬化症生活质量量表-54 (MSQOL-54)× | |
|---|---|---|
| 领域 | 神经病学 | 神经病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1999 | 1995 |
| 提出者≠ | James M. Cedarbaum, NIH/NINDS | Barbara G. Vickrey, UCLA |
| 类型≠ | Clinician-rated and patient-reported hybrid | Self-report questionnaire |
| 开创性文献≠ | Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169(1-2), 13-21. DOI ↗ | Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1995). Outcomes in Multiple Sclerosis: The Multiple Sclerosis Quality of Life-54 Scale. Health Psychology, 14(1), 34-42. DOI ↗ |
| 别名≠ | ALS FRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised | MS QoL-54 |
| 相关 | 4 | 4 |
| 摘要≠ | The ALSFRS-R is a 12-item clinician-administered functional rating scale designed to assess disease progression and functional status in amyotrophic lateral sclerosis (ALS). Introduced by Cedarbaum and colleagues in 1999, it expands upon the original ALSFRS by incorporating respiratory function assessment. It is the primary outcome measure in ALS clinical trials and routine clinical monitoring, providing quantitative tracking of disease decline that predicts survival and guides management decisions. | The MSQOL-54 is a disease-specific quality-of-life instrument designed to assess the physical and mental burden of multiple sclerosis on patients' daily functioning and well-being. Developed by Vickrey and colleagues in 1995, it combines the widely-used SF-36 generic health questionnaire with 18 MS-specific items to provide comprehensive measurement of QoL in MS populations. This scale is a cornerstone tool in MS clinical research and patient monitoring. |
| ScholarGate数据集 ↗ |
|
|